首页 News 正文

The US stock market of Coherus Biosciences Inc. rose more than 30% after market hours. On December 26th local time, the US Food and Drug Administration (FDA) approved its new cancer drug UDENYCA& Reg; ONBODY. Udenyca is a biologically similar drug to Anjin's cancer drug Neulasta (pegfilgrastim).
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

六月清晨搅 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    30